Executive Committee

The Alliance Executive Committee is chaired by the Group Chair and includes the Group Vice Chair, Program Directors, and eight representatives elected from the Board of Directors, including four Principal Investigators from academic member institutions and four Principal Investigators from community member institutions. The Executive Committee sets the scientific agenda of the Group by approving protocols at the concept stage. In addition, the Executive Committee approves the appointment of the Chairs of the Disease and Modality committees and is responsible for the management of Group affairs.

Evanthia Galanis, MD
Group Chair

David Kozono, MD, PhD
Group Vice Chair

PROGRAM PRINCIPAL INVESTIGATORS
Isabelle Bedrosian, MD
Procedure-Based Therapy Program
Olwen Hahn, MD
Central Protocol Operations Program
Sumithra Mandrekar, PhD
Statistics and Data Management Program
Electra Paskett, PhD
Cancer Control Program
W. Fraser Symmans, MD
Translational Research Program

BOARD OF DIRECTORS REPRESENTATIVES
Abigail Caudle, MD
University of Texas MD Anderson Cancer Center LAPS
Konstantin Dragnev, MD
Dartmouth College-Dartmouth Cancer Center LAPS
Bryan Faller, MD
Heartland Cancer Research NCORP
William Irvin, MD
Southeast Clinical Oncology Research Consortium NCORP
Gregory Masters, MD
Delaware/Christiana Care NCI Community Oncology Research Program
Matthew Milowsky, MD
UNC Lineberger Comprehensive Cancer Center
Ronica Nanda, MD
Morton Plant Hospital
Claire Verschraegen, MD
Ohio State University Comprehensive Cancer Center LAPS

AD HOC REPRESENTATIVES
Steven Piantadosi, MD, PhD
Strategic Initiatives and Innovation
Patty Spears
Patient Advocacy
Mark Watson, MD, PhD
Biorepository Systems
Kimberly Kerstann, PhD
Chief Operating Officer | Liaison - Administrative